HKSE:1530

3SBio Inc. · HKSE · Healthcare · HKD · FY for 2025

Figures on this page computed 2026-11-08 13:20 UTC

Last close

n/aHKD

Market data

  • 3.8xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • computed
    • Computed from the filing for 2025
  • n/aROIC

    We do not hold this figure for this company, so there is nothing to place.

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 47.9%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 51.6%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDebt/equity

    We do not hold this figure for this company, so there is nothing to place.

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 1.8%Dividend yield
    Source
    computed
    Taken on
    2026-11-08
    Reported in
    HKD
    • computed

Five bars, one line

lens 7 of 9
2.53x
4.16x
5.01x
0.76x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales2.53x

    Its own average over 10 years, 6.99B.

  • Profit4.16x

    Its own average over 10 years, 2.04B.

  • Free cash flow5.01x

    Its own average over 10 years, 1.82B.

  • Debt0.76x

    Its own average over 10 years, 3.46B.

  • Pricen/a

    Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 5.01 times.

Sales is 2.53 times its own 10-year average; Profit is 4.16 times its own 10-year average; Free cash flow is 5.01 times its own 10-year average; Debt is 0.76 times its own 10-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 10-year average2.53
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Profit against its own 10-year average4.16
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Free cash flow against its own 10-year average5.01
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Debt against its own 10-year average0.76
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    CNY
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    HKD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.